Neumora Therapeutics, Inc. Strategic Asset Allocation Index
Neumora Therapeutics, Inc. strategic asset allocation index. Neumora Therapeutics, Inc. (NMRA) has a Strategic Asset Allocation Index of 0.0% as of December 2024. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $287.06 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Neumora Therapeutics, Inc. (NMRA) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Neumora Therapeutics, Inc. (2023–2024)
Strategic asset allocation index of Neumora Therapeutics, Inc. from 2023 to 2024. This chart shows how Neumora Therapeutics, Inc.'s Strategic Asset Allocation Index has evolved across 2 annual periods from 2023 to 2024. As of December 2024, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $287.06 Million USD. Check Neumora Therapeutics, Inc. tangible equity quality to evaluate the tangible quality of the company's equity base.
Neumora Therapeutics, Inc. Strategic Asset Allocation Index by Year (2023–2024)
Neumora Therapeutics, Inc. strategic asset allocation index by year from 2023 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Neumora Therapeutics, Inc. from 2023 to 2024, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see NMRA stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.0% | $0.00 | $- | $0.00 | $287.06 Million | ▼ -2.1 pp |
| 2023 | 2.1% | $9.85 Million | $- | $9.85 Million | $469.08 Million | — |